91 related articles for article (PubMed ID: 16388189)
1. Vascular endothelial growth factor plasma levels are significantly elevated in patients with cerebral arteriovenous malformations.
Sandalcioglu IE; Wende D; Eggert A; Müller D; Roggenbuck U; Gasser T; Wiedemayer H; Stolke D
Cerebrovasc Dis; 2006; 21(3):154-8. PubMed ID: 16388189
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of vascular endothelial growth factor after treatment for cerebral arteriovenous malformations.
Kim GH; Hahn DK; Kellner CP; Hickman ZL; Komotar RJ; Starke RM; Mack WJ; Mocco J; Solomon RA; Connolly ES
Stroke; 2008 Aug; 39(8):2274-9. PubMed ID: 18535271
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
5. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
6. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations.
Moneib HA; Salem SA; Aly DG; Khedr HT; Wafaey HA; Hassan HE
J Dermatol; 2012 Jan; 39(1):52-7. PubMed ID: 21950586
[TBL] [Abstract][Full Text] [Related]
7. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization.
Tsai DC; Charng MJ; Lee FL; Hsu WM; Chen SJ
Ophthalmologica; 2006; 220(4):246-51. PubMed ID: 16785756
[TBL] [Abstract][Full Text] [Related]
8. Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
Starke RM; Komotar RJ; Hwang BY; Hahn DK; Otten ML; Hickman ZL; Garrett MC; Sisti MB; Lavine SD; Meyers PM; Solomon RA; Connolly ES
Neurosurgery; 2010 Feb; 66(2):343-8; discussion 348. PubMed ID: 20087134
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
10. Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension.
Tsai WC; Li YH; Huang YY; Lin CC; Chao TH; Chen JH
Clin Sci (Lond); 2005 Jul; 109(1):39-43. PubMed ID: 15740459
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.
Qian CN; Zhang CQ; Guo X; Hong MH; Cao SM; Mai WY; Min HQ; Zeng YX
Cancer; 2000 Jan; 88(2):255-61. PubMed ID: 10640954
[TBL] [Abstract][Full Text] [Related]
12. Endovascular treatment increases but gamma knife radiosurgery decreases angiogenic activity of arteriovenous malformations: an in vivo experimental study using a rat cornea model.
Akakin A; Ozkan A; Akgun E; Koc DY; Konya D; Pamir MN; Kilic T
Neurosurgery; 2010 Jan; 66(1):121-9; discussion 129-30. PubMed ID: 20023542
[TBL] [Abstract][Full Text] [Related]
13. Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations.
Sandalcioglu IE; Asgari S; Wende D; van de Nes JA; Dumitru CA; Zhu Y; Gizewski ER; Stolke D; Sure U
Cerebrovasc Dis; 2010; 30(4):396-401. PubMed ID: 20693795
[TBL] [Abstract][Full Text] [Related]
14. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
15. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
16. [Study on the role of angiogenesis and related factors in leukemias].
Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
[TBL] [Abstract][Full Text] [Related]
17. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
18. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
Sonmez K; Drenser KA; Capone A; Trese MT
Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
[TBL] [Abstract][Full Text] [Related]
19. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
[TBL] [Abstract][Full Text] [Related]
20. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
